2-methylene-19,21-dinor-1alpha-hydrox y-bishomopregnacalciferol

Details for Australian Patent Application No. 2005309820 (hide)

Owner Wisconsin Alumni Research Foundation

Inventors Deluca, Hector F.; Plum, Lori A.; Clagett-Dame, Margaret

Agent Spruson & Ferguson

Pub. Number AU-B-2005309820

PCT Pub. Number WO2006/057915

Priority 60/629,958 22.11.04 US

Filing date 18 November 2005

Wipo publication date 1 June 2006

Acceptance publication date 23 June 2011

International Classifications

C07C 401/00 (2006.01) Irradiation products of cholesterol or its derivatives

A61K 31/59 (2006.01) - Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems

Event Publications

14 June 2007 PCT application entered the National Phase

  PCT publication WO2006/057915 Priority application(s): WO2006/057915

23 June 2011 Application Accepted

  Published as AU-B-2005309820

20 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005309826-Piperidinyl piperidine tachykinin receptor antagonists

2005309819-2-methylene-19-nor-(20S)-1alpha-hydro xy-trishomopregnacalciferol